Detalhe da pesquisa
1.
New Approaches in Immunotherapy for the Treatment of Lung Cancer.
Curr Top Microbiol Immunol
; 405: 1-31, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-25522903
2.
A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma.
Blood
; 125(26): 4024-31, 2015 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25887777
3.
ATX-101, a cell-penetrating protein targeting PCNA, can be safely administered as intravenous infusion in patients and shows clinical activity in a Phase 1 study.
Oncogene
; 42(7): 541-544, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564469